Wire Stories

Wisk and Skyports Partner to Define Autonomous AAM Infrastructure Operations

Partnership Releases First-of-its-Kind Concept of Operations for Autonomous Advanced Air Mobility MOUNTAIN VIEW, Calif. & LONDON--(BUSINESS WIRE)--Wisk Aero, a leading…

5 years ago

Khoros Champions Agent Health with Platform Enhancements for Digital Contact Centers

The company’s 2022 Spring Innovation Release includes new AI for agents, expanded channels for engagement, and predictive workflows to meet…

5 years ago

Intercontinental Exchange and McLaren Racing Launch New Partnership With Amplified Focus on Sustainability and Diversity

ICE will Become a Sponsor of McLaren’s Extreme E Team, the Innovative New Series Featuring All-Electric Off-Road Competition with Male…

5 years ago

CHINT’s Path to CSR: Four Years of Dedication in Egypt

SHANGHAI--(BUSINESS WIRE)--CHINT values nothing higher than its responsibility to the community. CHINT’s subsidiary in Egypt established roots in the local…

5 years ago

TDCX to Present at Investor Conference – HSBC Virtual Series: ASEAN Software and IT Services

SINGAPORE--(BUSINESS WIRE)--TDCX Inc. (“TDCX” or the “Company”) (NYSE: TDCX), a high-growth digital customer experience solutions provider for technology and blue-chip…

5 years ago

VistaGen and AffaMed Complete Key Regulatory Submissions for PALISADE Global Phase 3 Clinical Trial for PH94B

Companies plan to initiate the global study of PH94B for the acute treatment of social anxiety disorder (SAD) in the…

5 years ago

Veritone and OOONA Partner to Create Synthetic Audio Description for Silver Trak Digital

Strategic technology partnership integrates the power of Veritone Voice in OOONA’s platform for the creation and management of media localization…

5 years ago

Alucent Biomedical Announces First Patient Enrolled in First In Human Natural Vascular Scaffolding Clinical Trial

Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc. announced that…

5 years ago

Takeda’s TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Children Ages 2 to <12 Years of Age With Hereditary Angioedema (HAE)

SHP643-301 is A Multicenter, Open-Label Phase 3 Study to Evaluate Safety, PK, Pharmacodynamics, And Clinical Activity/Outcomes of TAKHZYRO for Prevention…

5 years ago

California EV Company Fisker (NYSE: FSR) Selects Hyderabad as Headquarters for Initial Operations in India

Hyderabad in Telangana State selected as headquarters for Fisker's operations in India. Hon'ble Minister for IT and industries K.T. Rama…

5 years ago